e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
New aspects of cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: The activity of selected salivary proteases and glycosidases in whole saliva of cystic fibrosis patients
L. Minarowski, A. Minarowska, D. Sands, A. Karwowska, M. Knas, S. Szajda, E. Chyczewska (Bialystok, Warsaw, Poland)
Source:
Annual Congress 2010 - New aspects of cystic fibrosis
Session:
New aspects of cystic fibrosis
Session type:
Thematic Poster Session
Number:
4793
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Minarowski, A. Minarowska, D. Sands, A. Karwowska, M. Knas, S. Szajda, E. Chyczewska (Bialystok, Warsaw, Poland). Late Breaking Abstract: The activity of selected salivary proteases and glycosidases in whole saliva of cystic fibrosis patients. Eur Respir J 2010; 36: Suppl. 54, 4793
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Excerpts from the upcoming ERS Monograph on COVID-19
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
The activity of selected proteolytic enzymes in saliva of cystic fibrosis patients
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Late Breaking Abstract - Association of lung clearance index with survival in patients with cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
Neutrophil functional activity of patients with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Neutrophil functional activity of patients with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004
Late Breaking Abstract - Assessment of a ciliary transport protein in airway cells reveals novel pattern in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011
Disease modifying genes: The cystic fibrosis lesson
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004
Inhibition of airway proteases in cystic fibrosis lung disease
Source: Eur Respir J 2008; 32: 783-795
Year: 2008
Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Serum bactericidal activity in non cystic fibrosis bronchiectasis in patients with
pseudomonas aeruginosa
colonisation
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Dropping acid: why is cystic fibrosis mucus abnormal?
Source: Eur Respir J, 52 (6) 1802057; 10.1183/13993003.02057-2018
Year: 2018
Definition of trypsin-like enzymes activity as the marker of severity of idiopathic pulmonary fibrosis
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Association between lobe specific bronchoalveolar lavage fluid metabolites and structural lung disease in young children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Dysregulation of the expression and activity of antimicrobial peptides in COPD and cystic fibrosis
Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Year: 2018
Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Peptide transport mechanisms in cystic fibrosis and normal human lung
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001
Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Late Breaking Abstract - Short-term effects of a novel bronchial drainage device in Cystic Fibrosis patients
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
New insights into the pathophysiology of lung disease in cystic fibrosis patients
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept